The Summit for Healthcare Innovation
MedCity CONVERGE provides the most accurate picture of the future of medical innovation by gathering decision-makers from every sector to debate the challenges and opportunities facing the industry.
This national, executive-level summit gathers leaders from health systems, payers, medical device, pharma and digital health/health IT to join with entrepreneurs, government leaders, investors and other key stakeholders to see the latest innovations and create, through their conversations, truly actionable intelligence on where the innovation opportunities are right now.
The Science Center has partnered with MedCity News to allow a special discount to our network. Use code SCIENCECTR when you register, and you’ll have access to a Special Rate ticket of only $400 – a savings of $500 off the full onsite price. Register now to save!
Click here to read more.
In September’s Office hours, master how to talk to the media with award winning writer and editor, Elise Vider who will be available to answer questions and advise you on how to speak to the media. Click here to read more.
Dr. Gary Beauchamp, Emeritus Director and President of the Monell Chemical Sciences Center in Philadelphia, will be discussing the therapeutic benefits of olive oil. Dr. Beauchamp and his team identified a compound in olive oil they called oleocanthal, which possesses properties similar to the nonsteroidal anti-inflammatory (NSAID) known as ibuprofen. It was discovered during experiments to understand the off taste of ibuprofen, and since then studies have shown the effectiveness of oleocanthal in reducing amyloid plaques in Alzheimer patients and in treating various cancers using in vitro models.Click here to read more.
Coffee & Capital brings Sam Landman of Comcast Ventures to Quorum to meet with a small group of entrepreneurs over coffee and a light breakfast for an informal Q&A session about funding and pitching. This program is sponsored by Dolfinger-McMahon Foundation. Click here to read more.
Join us for an overview of SBIR/STTR eligibility requirements, NIH SBIR/STTR process and new cancer-focused funding opportunities from NCI, new NCI SBIR/STTR initiatives such as NIH Innovation Corps (I-CorpsT) Team Training Program, NCI Investor Forum to help NCI SBIR-funded companies to connect with investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries, practical strategies on how to successfully submit competitive research proposals. Click here to read more.
With over 30 years of experience in design, marketing, communication, and brand strategy- popular speaker, panelist, teacher, and facilitator Orly Zeewy is the host of Octobers, Brand Alignment Office Hours. Click here to read more.
PACT works to position its members toward growth and success. As a premier signature event of PACT, IMPACT Capital Conference has a long tradition of uniting key players from the private equity, venture capital, and entrepreneurial communities. As the oldest, most established venture conference in the Northeast, IMPACT draws more than 1,000 participants and has been the catalyst for billions of dollars in venture funding and entrepreneurial success.
IMPACT 2015 will continue to highlight emerging markets, capital resources, and innovation in the region as we continue the tradition of connecting capital and companies.
We welcome our new Host and Chairperson’s Michael Heller & Ira Gubernick of Cozen O’Connor LLP.
Click here to read more.
For a complete listing of regional events, go to our Regional Calendar